Reliability and expertise in the country and in the company are the convincing factors in selecting a business location. We can be justifiably proud but can still become even more attractive. This is something Austria should increasingly work on in the future!
The focus is on cancerous and inflammatory diseases, pain, cardiovascular diseases as well as rare diseases, amongst others. Pfizer relies on the extensive potential of biotherapeutics and targeted therapies in its development of new forms of treatment.
